Death is an otherwise universal reality that affects everyone, making cryonics deeply personal for those who seek it as a first science-based stop-gap solution to biological death. Cryonics aims to preserve the brain’s structure and information with the hope that future advances will enable revival and healing. However, cryonics providers must balance operational and commercial priorities, which can sometimes slow their incorporation of cutting-edge research. Yet breakthroughs like MEDY—whose pioneering application achieved the first documented partial reanimation of a human brain in 2024—are precisely the kind of innovations that matter most to their clients. By voicing demand for the latest technology and actively supporting these developments, customers can help ensure companies dedicate the resources needed for rigorous evaluation and implementation.

In cryonics, a field filled with hope and potential, exploration and integration of new technologies sits too stagnant due to the relatively small number of companies needing a strong business case for investment. As the "customers" (members), families of patients, potential customers, and supporters of cryonics, it's our job to create the demand for new tech investments. The time has come to reignite the drive that once propelled cryonics into the spotlight as a promising solution to combat the otherwise inevitability of death. Preserving the brain’s delicate structures and neuronal information is critical, as this is where our identities reside, and the promise of future scientific breakthroughs can give individuals a second chance at life — a hope that should be accessible to all, not a few.

Recent advancements, such as those exemplified by MEDY, a promising technique designed to enhance the preservation process, have not received the attention they deserve. Delaying the adoption and rigorous analysis of these advancements deprives potential beneficiaries today while we await a future where revival becomes a biological reality. To move forward, cryonics organizations must adopt a new momentum, characterized by relentless analysis and application of scientific research.

Members and supporters of cryonics must unite to demand a more proactive approach, urging organizations to engage with modern scientific developments and explore and implement them with the urgency they require. By fostering a culture that prioritizes continuous learning and adaptation, cryonics can not only preserve hope for the individuals it aims to serve but also truly advance as a scientific endeavor.

Sign this petition to encourage cryonics organizations to step up their commitment, thoroughly analyze budding technologies like MEDY, and embrace innovative methodologies for the future of life preservation.